---
schema_version: "secwatch.filing_event.v1"
accession: "0001295947-24-000023"
form_type: "8-K"
ticker: "PBH"
cik: "0001295947"
company_name: "Prestige Consumer Healthcare Inc."
filed_at: "2024-08-08T23:59:59+00:00"
generated_at: "2026-05-31T10:43:05.446478+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Prestige Consumer Q1 revenue $267.1M beats expectations; reaffirms FY2025 outlook

## Summary
- Q1 GAAP EPS $0.98, adjusted EPS $0.90; revenue down 4.4% YoY but ahead of internal plan.
- Cash from operations $54.8M (+13.9% YoY); reduced debt $35M and repurchased $26M in shares.
- North American OTC revenue $232.3M (-5.6%); International OTC $34.8M (+5.0% driven by Hydralyte).
- FY2025 guidance reaffirmed: revenue $1.125-$1.140B, adjusted EPS $4.40-$4.46, FCF $240M+.
- CEO cited earlier supply of Clear Eyes products as primary driver of Q1 beat over expectations.

## SEC filing metadata
- accession: 0001295947-24-000023
- form_type: 8-K
- ticker: PBH
- cik: 0001295947
- company_name: Prestige Consumer Healthcare Inc.
- filed_at: 2024-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1295947/000129594724000023/0001295947-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1295947/000129594724000023/pbh-20240808.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001295947-24-000023
- JSON: https://secwatch.observer/filing/0001295947-24-000023.json
- Plain text: https://secwatch.observer/filing/0001295947-24-000023.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.